Researchers identify new genes that modulate the toxicity of the protein β-amyloid, responsible for causing Alzheimer’s

March 21, 2023

An international study led by the Molecular Physiology Laboratory at the UPF Department of Medicine and Life Sciences (MELIS) identifies new genes that modulate the toxicity of the protein β-amyloid, responsible for causing Alzheimer’s disease.

Trump administration puts freeze on release of health info from government agencies
President Donald Trump's administration has placed a freeze on information being released from government health agencies.
Light-activated ink developed to remotely control cardiac tissue to repair the heart
Researchers from Mass General Brigham and collaborating institutions have developed a non-invasive approach to manipulate cardiac tissue activity by using light to stimulate an innovative ink incorporated into bioprinted tissue. Their goal is to develop a technique that can be used to repair the heart. Their findings in preclinical models, published in Science Advances, show the transformative potential of non-invasive therapeutic methods to control electrically active tissues.
Researchers pinpoint keys to cell therapy response for leukemia
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have relapsed after allogenic hematopoietic stem cell transplant, will successfully move the patient into remission. The team identified that a key cell type in the DLI product and features of the tumor microenvironment in patients both play a role.
VR subway experiment highlights role of sound in disrupting balance for people with inner ear disorder
The vestibular system is a network of organs in the inner ears that detects the motions and position of the head. The brain uses this information, along with inputs from the eyes and joints, to maintain the body's balance.
Lower dexamethasone dose does not impair survival in multiple myeloma
For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.

Researchers identify new genes that modulate the toxicity of the protein β-amyloid, responsible for causing Alzheimer’s

Recent Posts

JUST IN